Related Experiment Video
Updated: May 22, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
AD Workbench: Transforming Alzheimer's research with secure, global, and collaborative data sharing and analysis
Caitlin P McHugh1, Matthew H S Clement1, Mukta Phatak1
1Alzheimer's Disease Data Initiative, Kirkland, Washington, USA.
The Alzheimer's Disease Data Initiative (AD Data Initiative) offers AD Workbench, a cloud platform enhancing global collaboration and data sharing for Alzheimer's disease research. This secure environment accelerates discoveries and the development of new treatments and diagnostics.
Area of Science:
- Neuroscience
- Data Science
- Medical Informatics
Background:
- The Alzheimer's Disease Data Initiative (AD Data Initiative) is a global partnership focused on accelerating Alzheimer's disease (AD) and related dementias (ADRD) research.
- It aims to overcome data silos and research barriers through scientific collaboration.
Purpose of the Study:
- To introduce AD Workbench as a key technological solution from the AD Data Initiative.
- To highlight its role in facilitating global access, analysis, and sharing of crucial research data.
Main Methods:
- Development of AD Workbench, a secure, cloud-based research environment.
- Ensuring interoperability with other major data platforms.
Main Results:
- AD Workbench has 6178 registered users from 115 countries as of April 2025.
- Includes 886 users from 60 low- and middle-income countries.
- Attracts over 500 monthly users for data discovery and integrative analysis.
Conclusions:
- AD Workbench promotes data sharing, interoperability, and collaborative research in a secure, cloud-based environment.
- It is poised to advance the development of diagnostic tools and treatments for Alzheimer's disease.
More Related Videos
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016